Mitochondria: Hub of injury responses in the developing brain

The Lancet Neurology

Volumn 13, Issue 2, 2014, Pages 217-232

  Hagberg, Henrik ^a,b   Mallard, Carina ^b   Rousset, Catherine I ^a   Thornton, Claire ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 33; PATTERN RECOGNITION RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

APOPTOSIS; BIOENERGY; BIOGENESIS; BRAIN DEVELOPMENT; BRAIN HYPOXIA; BRAIN INFECTION; BRAIN INJURY; BRAIN MITOCHONDRION; CELL FATE; HOST RESISTANCE; HUMAN; INFLAMMATION; INNATE IMMUNITY; MEMBRANE PERMEABILITY; MITOPHAGY; MORPHOGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

ANIMALS; ANIMALS, NEWBORN; BRAIN; BRAIN INJURIES; MITOCHONDRIA; NEURONS;

EID: 84892517669     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(13)70261-8     Document Type: Review

References (205)

1. Ferriero DM Neonatal brain injury. N Engl J Med 2004, 351:1985-1995.
2. Volpe JJ Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009, 8:110-124.
3. Johnston MV, Fatemi A, Wilson MA, Northington F Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol 2011, 10:372-382.
4. Azzopardi D, Strohm B, Linsell L, et al. Implementation and conduct of therapeutic hypothermia for perinatal asphyxial encephalopathy in the UK-analysis of national data. PLoS One 2012, 7:e38504. the UK TOBY Cooling Register.
5. Thornton C, Rousset CI, Kichev A, et al. Molecular mechanisms of neonatal brain injury. Neurol Res Int 2012, 2012:506320.
6. Fleiss B, Gressens P Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy?. Lancet Neurol 2012, 11:556-566.
7. Rousset CI, Baburamani AA, Thornton C, Hagberg H Mitochondria and perinatal brain injury. J Matern Fetal Neonatal Med 2012, 25(suppl 1):35-38.
8. Hagberg H, Gressens P, Mallard C Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann Neurol 2012, 71:444-457.
9. Green DR, Galluzzi L, Kroemer G Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 2011, 333:1109-1112.
10. Song W, Chen J, Petrilli A, et al. Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 2011, 17:377-382.
11. Seo AY, Joseph AM, Dutta D, Hwang JC, Aris JP, Leeuwenburgh C New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J Cell Sci 2010, 123:2533-2542.
12. Cowell RM, Blake KR, Russell JW Localization of the transcriptional coactivator PGC-1alpha to GABAergic neurons during maturation of the rat brain. J Comp Neurol 2007, 502:1-18.
13. Sheridan C, Martin SJ Mitochondrial fission/fusion dynamics and apoptosis. Mitochondrion 2010, 10:640-648.
14. Frederick RL, Shaw JM Moving mitochondria: establishing distribution of an essential organelle. Traffic 2007, 8:1668-1675.
15. Hiona A, Sanz A, Kujoth GC, et al. Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoS One 2010, 5:e11468.
16. Grivennikova VG, Kareyeva AV, Vinogradov AD What are the sources of hydrogen peroxide production by heart mitochondria?. Biochim Biophys Acta 2010, 1797:939-944.
17. Gottlieb RA, Carreira RS Autophagy in health and disease. 5. Mitophagy as a way of life. Am J Physiol Cell Physiol 2010, 299:C203-C210.
18. Scarpulla RC Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta 2011, 1813:1269-1278.
19. Wenz T Regulation of mitochondrial biogenesis and PGC-1α under cellular stress. Mitochondrion 2013, 13:134-142.
20. Wu Z, Puigserver P, Andersson U, et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999, 98:115-124.
21. Huss JM, Kopp RP, Kelly DP Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J Biol Chem 2002, 277:40265-40274.
22. Attardi G, Schatz G Biogenesis of mitochondria. Annu Rev Cell Biol 1988, 4:289-333.
23. Koehler CM Protein translocation pathways of the mitochondrion. FEBS Lett 2000, 476:27-31.
24. Larsson NG, Wang J, Wilhelmsson H, et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 1998, 18:231-236.
25. Tanaka A, Youle RJ A chemical inhibitor of DRP1 uncouples mitochondrial fission and apoptosis. Mol Cell 2008, 29:409-410.
26. Otera H, Ishihara N, Mihara K New insights into the function and regulation of mitochondrial fission. Biochim Biophys Acta 2013, 1833:1256-1268.
27. Onoue K, Jofuku A, Ban-Ishihara R, et al. Fis1 acts as a mitochondrial recruitment factor for TBC1D15 that is involved in regulation of mitochondrial morphology. J Cell Sci 2013, 126:176-185.
28. Benard G, Karbowski M Mitochondrial fusion and division: Regulation and role in cell viability. Semin Cell Dev Biol 2009, 20:365-374.
29. Ashrafi G, Schwarz TL The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ 2013, 20:31-42.
30. Levine B, Kroemer G Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
31. Kubli DA, Gustafsson AB Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 2012, 111:1208-1221.
32. Liu L, Feng D, Chen G, et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol 2012, 14:177-185.
33. Nehlig A, de Vasconcelos AP, Boyet S Quantitative autoradiographic measurement of local cerebral glucose utilization in freely moving rats during postnatal development. J Neurosci 1988, 8:2321-2333.
34. Kreisman NR, Olson JE, Horne DS, Holtzman D Cerebral oxygenation and blood flow in infant and young adult rats. Am J Physiol 1989, 256:R78-R85.
35. Duffy TE, Kohle SJ, Vannucci RC Carbohydrate and energy metabolism in perinatal rat brain: relation to survival in anoxia. J Neurochem 1975, 24:271-276.
36. Samson FE, Balfour WM, Dahl NA The effect of age and temperature on the cerebral energy requirement in the rat. J Gerontol 1958, 13:248-251.
37. Siesjo BK Brain energy metabolism 1978, Wiley, New York.
38. Vannucci RC, Vannucci SJ Cerebral carbohydrate metabolism during hypoglycemia and anoxia in newborn rats. Ann Neurol 1978, 4:73-79.
39. 14C]iodoantipyrine technique in freely moving rats. J Cereb Blood Flow Metab 1989, 9:579-588.
40. Hagberg H, Bona E, Gilland E, Puka-Sundvall M Hypoxia-ischaemia model in the 7-day-old rat: possibilities and shortcomings. Acta Paediatr Suppl 1997, 422:85-88.
41. Tucker AM, Aquilina K, Chakkarapani E, Hobbs CE, Thoresen M Development of amplitude-integrated electroencephalography and interburst interval in the rat. Pediatr Res 2009, 65:62-66.
42. Erecinska M, Cherian S, Silver IA Energy metabolism in mammalian brain during development. Prog Neurobiol 2004, 73:397-445.
43. Samson FE, Balfour WM, Dahl NA Rate of cerebral ATP utilization in rats. Am J Physiol 1960, 198:213-216.
44. Dahl DR, Samson FE Metabolism of rat brain mitochondria during postnatal development. Am J Physiol 1959, 196:470-472.
45. Land JM, Booth RF, Berger R, Clark JB Development of mitochondrial energy metabolism in rat brain. Biochem J 1977, 164:339-348.
46. Zhu C, Qiu L, Wang X, et al. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J Neurochem 2003, 86:306-317.
47. Cannino G, Di Liegro CM, Di Liegro I, Rinaldi AM Analysis of cytochrome C oxidase subunits III and IV expression in developing rat brain. Neuroscience 2004, 128:91-98.
48. Gregson NA, Williams PL A comparative study of brain and liver mitochondria from new-born and adult rats. J Neurochem 1969, 16:617-626.
49. Pysh JJ Mitochondrial changes in rat inferior colliculus during postnatal development: an electron microscopic study. Brain Res 1970, 18:325-342.
50. Schaper J, Meiser E, Stämmler G Ultrastructural morphometric analysis of myocardium from dogs, rats, hamsters, mice, and from human hearts. Circ Res 1985, 56:377-391.
51. Robertson CL, Bucci CJ, Fiskum G Mitochondrial response to calcium in the developing brain. Brain Res Dev Brain Res 2004, 151:141-148.
52. Vayssière JL, Cordeau-Lossouarn L, Larcher JC, Basseville M, Gros F, Croizat B Participation of the mitochondrial genome in the differentiation of neuroblastoma cells. In Vitro Cell Dev Biol 1992, 28A:763-772.
53. Mattson MP, Gleichmann M, Cheng A Mitochondria in neuroplasticity and neurological disorders. Neuron 2008, 60:748-766.
54. Cheng A, Wan R, Yang JL, et al. Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines. Nat Commun 2012, 3:1250.
55. Lin J, Wu PH, Tarr PT, et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004, 119:121-135.
56. Liu QA, Shio H Mitochondrial morphogenesis, dendrite development, and synapse formation in cerebellum require both Bcl-w and the glutamate receptor delta2. PLoS Genet 2008, 4:e1000097.
57. Li Z, Okamoto K, Hayashi Y, Sheng M The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004, 119:873-887.
58. Ishihara N, Nomura M, Jofuku A, et al. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol 2009, 11:958-966.
59. Waterham HR, Koster J, van Roermund CW, Mooyer PA, Wanders RJ, Leonard JV A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med 2007, 356:1736-1741.
60. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 2003, 160:189-200.
61. Züchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004, 36:449-451.
62. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 2000, 26:207-210.
63. Vekrellis K, McCarthy MJ, Watson A, Whitfield J, Rubin LL, Ham J Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development 1997, 124:1239-1249.
64. Soane L, Siegel ZT, Schuh RA, Fiskum G Postnatal developmental regulation of Bcl-2 family proteins in brain mitochondria. J Neurosci Res 2008, 86:1267-1276.
65. Zhu C, Wang X, Xu F, et al. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ 2005, 12:162-176.
66. Kuroda S, Janelidze S, Siesjö BK The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats. Brain Res 1999, 835:148-153.
67. Schinzel AC, Takeuchi O, Huang Z, et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci USA 2005, 102:12005-12010.
68. Wang X, Carlsson Y, Basso E, et al. Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. J Neurosci 2009, 29:2588-2596.
69. Puka-Sundvall M, Gilland E, Hagberg H Cerebral hypoxia-ischemia in immature rats: involvement of mitochondrial permeability transition?. Dev Neurosci 2001, 23:192-197.
70. Wang X, Han W, Du X, et al. Neuroprotective effect of Bax-inhibiting peptide on neonatal brain injury. Stroke 2010, 41:2050-2055.
71. Macaskill AF, Rinholm JE, Twelvetrees AE, et al. Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 2009, 61:541-555.
72. MacAskill AF, Brickley K, Stephenson FA, Kittler JT GTPase dependent recruitment of Grif-1 by Miro1 regulates mitochondrial trafficking in hippocampal neurons. Mol Cell Neurosci 2009, 40:301-312.
73. Wilson TJ, Slupe AM, Strack S Cell signaling and mitochondrial dynamics: Implications for neuronal function and neurodegenerative disease. Neurobiol Dis 2013, 51:13-26.
74. Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880-884.
75. Hara T, Nakamura K, Matsui M, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441:885-889.
76. Imai Y, Lu B Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder. Curr Opin Neurobiol 2011, 21:935-941.
77. Perez FA, Palmiter RD Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci USA 2005, 102:2174-2179.
78. Lorek A, Takei Y, Cady EB, et al. Delayed ("secondary") cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res 1994, 36:699-706.
79. Blumberg RM, Cady EB, Wigglesworth JS, McKenzie JE, Edwards AD Relation between delayed impairment of cerebral energy metabolism and infarction following transient focal hypoxia-ischaemia in the developing brain. Exp Brain Res 1997, 113:130-137.
80. Iwata O, Iwata S, Bainbridge A, et al. Supra- and sub-baseline phosphocreatine recovery in developing brain after transient hypoxia-ischaemia: relation to baseline energetics, insult severity and outcome. Brain 2008, 131:2220-2226.
81. Gilland E, Puka-Sundvall M, Hillered L, Hagberg H Mitochondrial function and energy metabolism after hypoxia-ischemia in the immature rat brain: involvement of NMDA-receptors. J Cereb Blood Flow Metab 1998, 18:297-304.
82. Vannucci RC, Yager JY, Vannucci SJ Cerebral glucose and energy utilization during the evolution of hypoxic-ischemic brain damage in the immature rat. J Cereb Blood Flow Metab 1994, 14:279-288.
83. Puka-Sundvall M, Gajkowska B, Cholewinski M, Blomgren K, Lazarewicz JW, Hagberg H Subcellular distribution of calcium and ultrastructural changes after cerebral hypoxia-ischemia in immature rats. Brain Res Dev Brain Res 2000, 125:31-41.
84. Gilland E, Hagberg H NMDA receptor-dependent increase of cerebral glucose utilization after hypoxia-ischemia in the immature rat. J Cereb Blood Flow Metab 1996, 16:1005-1013.
85. Penrice J, Lorek A, Cady EB, et al. Proton magnetic resonance spectroscopy of the brain during acute hypoxia-ischemia and delayed cerebral energy failure in the newborn piglet. Pediatr Res 1997, 41:795-802.
86. 18F]FDG positron emission tomography in infants with hypoxic-ischaemic encephalopathy shows hypermetabolism during the postasphyctic period. Acta Paediatr 1995, 84:1289-1295.
87. Northington FJ, Chavez-Valdez R, Graham EM, Razdan S, Gauda EB, Martin LJ Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J Cereb Blood Flow Metab 2011, 31:178-189.
88. Northington FJ, Chavez-Valdez R, Martin LJ Neuronal cell death in neonatal hypoxia-ischemia. Ann Neurol 2011, 69:743-758.
89. Wroge CM, Hogins J, Eisenman L, Mennerick S Synaptic NMDA receptors mediate hypoxic excitotoxic death. J Neurosci 2012, 32:6732-6742.
90. Hardingham GE, Bading H Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 2010, 11:682-696.
91. Ferriero DM, Holtzman DM, Black SM, Sheldon RA Neonatal mice lacking neuronal nitric oxide synthase are less vulnerable to hypoxic-ischemic injury. Neurobiol Dis 1996, 3:64-71.
92. Pirianov G, Brywe KG, Mallard C, et al. Deletion of the c-Jun N-terminal kinase 3 gene protects neonatal mice against cerebral hypoxic-ischaemic injury. J Cereb Blood Flow Metab 2007, 27:1022-1032.
93. Blomgren K, Zhu C, Wang X, et al. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"?. J Biol Chem 2001, 276:10191-10198.
94. Nijboer CH, Bonestroo HJ, Zijlstra J, Kavelaars A, Heijnen CJ Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuroinflammation and apoptosis after neonatal ischemic brain damage. Neurobiol Dis 2013, 54:432-444.
95. Puka-Sundvall M, Hallin U, Zhu C, et al. NMDA blockade attenuates caspase-3 activation and DNA fragmentation after neonatal hypoxia-ischemia. Neuroreport 2000, 11:2833-2836.
96. Ikonomidou C, Bosch F, Miksa M, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999, 283:70-74.
97. Tu W, Xu X, Peng L, et al. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 2010, 140:222-234.
98. Shamloo M, Soriano L, Wieloch T, Nikolich K, Urfer R, Oksenberg D Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia. J Biol Chem 2005, 280:42290-42299.
99. Cook DJ, Teves L, Tymianski M A translational paradigm for the preclinical evaluation of the stroke neuroprotectant Tat-NR2B9c in gyrencephalic nonhuman primates. Sci Transl Med 2012, 4:154ra133.
100. Cook DJ, Teves L, Tymianski M Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature 2012, 483:213-217.
101. Hill MD, Martin RH, Mikulis D, et al. Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2012, 11:942-950. the ENACT trial investigators.
102. Nair S, Hagberg H, Krishnamurthy R, Thornton C, Mallard C Death associated protein kinases: molecular structure and brain injury. Int J Mol Sci 2013, 14:13858-13872.
103. Peng TI, Greenamyre JT Privileged access to mitochondria of calcium influx through N-methyl-D-aspartate receptors. Mol Pharmacol 1998, 53:974-980.
104. Sanderson TH, Reynolds CA, Kumar R, Przyklenk K, Hüttemann M Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Mol Neurobiol 2013, 47:9-23.
105. 2 production by membrane potential and NAD(P)H redox state. J Neurochem 2003, 86:1101-1107.
106. Ramonet D, Perier C, Recasens A, et al. Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiency. Cell Death Differ 2013, 20:77-85.
107. Modjtahedi N, Giordanetto F, Madeo F, Kroemer G Apoptosis-inducing factor: vital and lethal. Trends Cell Biol 2006, 16:264-272.
108. Krantic S, Mechawar N, Reix S, Quirion R Apoptosis-inducing factor: a matter of neuron life and death. Prog Neurobiol 2007, 81:179-196.
109. Boveris A, Cadenas E, Stoppani AO Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem J 1976, 156:435-444.
110. Turrens JF, Boveris A Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 1980, 191:421-427.
111. Zhu C, Wang X, Qiu L, Peeters-Scholte C, Hagberg H, Blomgren K Nitrosylation precedes caspase-3 activation and translocation of apoptosis-inducing factor in neonatal rat cerebral hypoxia-ischaemia. J Neurochem 2004, 90:462-471.
112. Ferriero DM, Sheldon RA, Black SM, Chuai J Selective destruction of nitric oxide synthase neurons with quisqualate reduces damage after hypoxia-ischemia in the neonatal rat. Pediatr Res 1995, 38:912-918.
113. Peeters-Scholte C, Koster J, Veldhuis W, et al. Neuroprotection by selective nitric oxide synthase inhibition at 24 hours after perinatal hypoxia-ischemia. Stroke 2002, 33:2304-2310.
114. Turrens JF Mitochondrial formation of reactive oxygen species. J Physiol 2003, 552:335-344.
115. Piantadosi CA, Zhang J Mitochondrial generation of reactive oxygen species after brain ischemia in the rat. Stroke 1996, 27:327-331.
116. Kudin AP, Malinska D, Kunz WS Sites of generation of reactive oxygen species in homogenates of brain tissue determined with the use of respiratory substrates and inhibitors. Biochim Biophys Acta 2008, 1777:689-695.
117. Wang X, Zhu C, Wang X, et al. X-linked inhibitor of apoptosis (XIAP) protein protects against caspase activation and tissue loss after neonatal hypoxia-ischemia. Neurobiol Dis 2004, 16:179-189.
118. Gill R, Soriano M, Blomgren K, et al. Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain. J Cereb Blood Flow Metab 2002, 22:420-430.
119. Galluzzi L, Blomgren K, Kroemer G Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 2009, 10:481-494.
120. Rasola A, Sciacovelli M, Pantic B, Bernardi P Signal transduction to the permeability transition pore. FEBS Lett 2010, 584:1989-1996.
121. Gibson ME, Han BH, Choi J, et al. BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: evidence for distinct apoptosis pathways. Mol Med 2001, 7:644-655.
122. Cheng Y, Deshmukh M, D'Costa A, et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998, 101:1992-1999.
123. Parsadanian AS, Cheng Y, Keller-Peck CR, Holtzman DM, Snider WD Bcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci 1998, 18:1009-1019.
124. Han BH, Holtzman DM BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000, 20:5775-5781.
125. Almli CR, Levy TJ, Han BH, Shah AR, Gidday JM, Holtzman DM BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia. Exp Neurol 2000, 166:99-114.
126. Han BH, D'Costa A, Back SA, et al. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol Dis 2000, 7:38-53.
127. Han BH, Xu D, Choi J, et al. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J Biol Chem 2002, 277:30128-30136.
128. Zhu C, Wang X, Deinum J, et al. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med 2007, 204:1741-1748.
129. Zhu C, Wang X, Huang Z, et al. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ 2007, 14:775-784.
130. Wang X, Zhu C, Wang X, et al. X-linked inhibitor of apoptosis (XIAP) protein protects against caspase activation and tissue loss after neonatal hypoxia-ischemia. Neurobiol Dis 2004, 16:179-189.
131. Ness JM, Harvey CA, Strasser A, Bouillet P, Klocke BJ, Roth KA Selective involvement of BH3-only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemia. Brain Res 2006, 1099:150-159.
132. West T, Stump M, Lodygensky G, Neil JJ, Deshmukh M, Holtzman DM Lack of X-linked inhibitor of apoptosis protein leads to increased apoptosis and tissue loss following neonatal brain injury. ASN Neuro 2009, 1:43-53.
133. Gao Y, Liang W, Hu X, et al. Neuroprotection against hypoxic-ischemic brain injury by inhibiting the apoptotic protease activating factor-1 pathway. Stroke 2010, 41:166-172.
134. Nijboer CH, Heijnen CJ, van der Kooij MA, et al. Targeting the p53 pathway to protect the neonatal ischemic brain. Ann Neurol 2011, 70:255-264.
135. Carlsson Y, Schwendimann L, Vontell R, et al. Genetic inhibition of caspase-2 reduces hypoxic-ischemic and excitotoxic neonatal brain injury. Ann Neurol 2011, 70:781-789.
136. Chauvier D, Renolleau S, Holifanjaniaina S, et al. Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor. Cell Death Dis 2011, 2:e203.
137. Northington FJ, Ferriero DM, Flock DL, Martin LJ Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci 2001, 21:1931-1938.
138. Hallin U, Kondo E, Ozaki Y, Hagberg H, Shibasaki F, Blomgren K Bcl-2 phosphorylation in the BH4 domain precedes caspase-3 activation and cell death after neonatal cerebral hypoxic-ischemic injury. Neurobiol Dis 2006, 21:478-486.
139. Karbowski M, Norris KL, Cleland MM, Jeong SY, Youle RJ Role of Bax and Bak in mitochondrial morphogenesis. Nature 2006, 443:658-662.
140. Frank S, Gaume B, Bergmann-Leitner ES, et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell 2001, 1:515-525.
141. Sugioka R, Shimizu S, Tsujimoto Y Fzo1, a protein involved in mitochondrial fusion, inhibits apoptosis. J Biol Chem 2004, 279:52726-52734.
142. Carloni S, Buonocore G, Balduini W Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury. Neurobiol Dis 2008, 32:329-339.
143. Ginet V, Puyal J, Clarke PG, Truttmann AC Enhancement of autophagic flux after neonatal cerebral hypoxia-ischemia and its region-specific relationship to apoptotic mechanisms. Am J Pathol 2009, 175:1962-1974.
144. Koike M, Shibata M, Tadakoshi M, et al. Inhibition of autophagy prevents hippocampal pyramidal neuron death after hypoxic-ischemic injury. Am J Pathol 2008, 172:454-469.
145. Hoshino A, Matoba S, Iwai-Kanai E, et al. p53-TIGAR axis attenuates mitophagy to exacerbate cardiac damage after ischemia. J Mol Cell Cardiol 2012, 52:175-184.
146. Yin W, Signore AP, Iwai M, Cao G, Gao Y, Chen J Rapidly increased neuronal mitochondrial biogenesis after hypoxic-ischemic brain injury. Stroke 2008, 39:3057-3063.
147. Shen S, Kepp O, Kroemer G The end of autophagic cell death?. Autophagy 2012, 8:1-3.
148. Kessel DH, Price M, Reiners JJ ATG7 deficiency suppresses apoptosis and cell death induced by lysosomal photodamage. Autophagy 2012, 8:1333-1341.
149. Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880-884.
150. Noble R The development of resistance by rats and guinea pigs to amount of trauma usually fatal. Am J Physiol 1943, 138:346-356.
151. Barks JD, Post M, Tuor UI Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat. Pediatr Res 1991, 29:558-563.
152. Gidday JM, Fitzgibbons JC, Shah AR, Park TS Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neurosci Lett 1994, 168:221-224.
153. Gustavsson M, Anderson MF, Mallard C, Hagberg H Hypoxic preconditioning confers long-term reduction of brain injury and improvement of neurological ability in immature rats. Pediatr Res 2005, 57:305-309.
154. Eklind S, Mallard C, Arvidsson P, Hagberg H Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr Res 2005, 58:112-116.
155. Hickey E, Shi H, Van Arsdell G, Askalan R Lipopolysaccharide-induced preconditioning against ischemic injury is associated with changes in toll-like receptor 4 expression in the rat developing brain. Pediatr Res 2011, 70:10-14.
156. Dirnagl U, Meisel A Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?. Neuropharmacology 2008, 55:334-344.
157. Correia SC, Carvalho C, Cardoso S, et al. Mitochondrial preconditioning: a potential neuroprotective strategy. Front Aging Neurosci 2010, 2.
158. Klimova T, Chandel NS Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ 2008, 15:660-666.
159. Shiva S, Sack MN, Greer JJ, et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 2007, 204:2089-2102.
160. Gidday JM, Shah AR, Maceren RG, et al. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J Cereb Blood Flow Metab 1999, 19:331-340.
161. Gustavsson M, Wilson MA, Mallard C, Rousset C, Johnston MV, Hagberg H Global gene expression in the developing rat brain after hypoxic preconditioning: involvement of apoptotic mechanisms?. Pediatr Res 2007, 61:444-450.
162. Baines CP, Song CX, Zheng YT, et al. Protein kinase Ce{open} interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res 2003, 92:873-880.
163. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006, 21:749-760.
164. Noguchi CT, Asavaritikrai P, Teng R, Jia Y Role of erythropoietin in the brain. Crit Rev Oncol Hematol 2007, 64:159-171.
165. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 2000, 48:285-296.
166. Sharp FR, Bernaudin M HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 2004, 5:437-448.
167. Sheldon RA, Osredkar D, Lee CL, Jiang X, Mu D, Ferriero DM HIF-1 alpha-deficient mice have increased brain injury after neonatal hypoxia-ischemia. Dev Neurosci 2009, 31:452-458.
168. Raval AP, Dave KR, DeFazio RA, Perez-Pinzon MA EPKC phosphorylates the mitochondrial K(+) (ATP) channel during induction of ischemic preconditioning in the rat hippocampus. Brain Res 2007, 1184:345-353.
169. Bednarczyk P Potassium channels in brain mitochondria. Acta Biochim Pol 2009, 56:385-392.
170. Bajgar R, Seetharaman S, Kowaltowski AJ, Garlid KD, Paucek P Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J Biol Chem 2001, 276:33369-33374.
171. Liu D, Lu C, Wan R, Auyeung WW, Mattson MP Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J Cereb Blood Flow Metab 2002, 22:431-443.
172. Rajapakse N, Shimizu K, Kis B, Snipes J, Lacza Z, Busija D Activation of mitochondrial ATP-sensitive potassium channels prevents neuronal cell death after ischemia in neonatal rats. Neurosci Lett 2002, 327:208-212.
173. Wang L, Zhu QL, Wang GZ, et al. The protective roles of mitochondrial ATP-sensitive potassium channels during hypoxia-ischemia-reperfusion in brain. Neurosci Lett 2011, 491:63-67.
174. Diano S, Matthews RT, Patrylo P, et al. Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology 2003, 144:5014-5021.
175. McFalls EO, Sluiter W, Schoonderwoerd K, et al. Mitochondrial adaptations within chronically ischemic swine myocardium. J Mol Cell Cardiol 2006, 41:980-988.
176. Lin HW, Thompson JW, Morris KC, Perez-Pinzon MA Signal transducers and activators of transcription: STATs-mediated mitochondrial neuroprotection. Antioxid Redox Signal 2011, 14:1853-1861.
177. Morris KC, Lin HW, Thompson JW, Perez-Pinzon MA Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning. J Cereb Blood Flow Metab 2011, 31:1003-1019.
178. Huang C, Andres AM, Ratliff EP, Hernandez G, Lee P, Gottlieb RA Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One 2011, 6:e20975.
179. Gutsaeva DR, Carraway MS, Suliman HB, et al. Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism. J Neurosci 2008, 28:2015-2024.
180. Gustavsson M, Mallard C, Vannucci SJ, Wilson MA, Johnston MV, Hagberg H Vascular response to hypoxic preconditioning in the immature brain. J Cereb Blood Flow Metab 2007, 27:928-938.
181. Akira S, Takeda K, Kaisho T Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680.
182. Janeway CA, Medzhitov R Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
183. Seong SY, Matzinger P Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004, 4:469-478.
184. Tannahill GM, O'Neill LA The emerging role of metabolic regulation in the functioning of Toll-like receptors and the NOD-like receptor Nlrp3. FEBS Lett 2011, 585:1568-1572.
185. Cloonan SM, Choi AM Mitochondria: commanders of innate immunity and disease?. Curr Opin Immunol 2012, 24:32-40.
186. West AP, Shadel GS, Ghosh S Mitochondria in innate immune responses. Nat Rev Immunol 2011, 11:389-402.
187. Krysko DV, Agostinis P, Krysko O, et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011, 32:157-164.
188. Arnoult D, Soares F, Tattoli I, Girardin SE Mitochondria in innate immunity. EMBO Rep 2011, 12:901-910.
189. Belgnaoui SM, Paz S, Hiscott J Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol 2011, 23:564-572.
190. Koshiba T, Yasukawa K, Yanagi Y, Kawabata S Mitochondrial membrane potential is required for MAVS-mediated antiviral signaling. Sci Signal 2011, 4:ra7.
191. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci USA 2009, 106:2770-2775.
192. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
193. West AP, Koblansky AA, Ghosh S Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 2006, 22:409-437.
194. Oka T, Hikoso S, Yamaguchi O, et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 2012, 485:251-255.
195. Akundi RS, Huang Z, Eason J, et al. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice. PLoS One 2011, 6:e16038.
196. Lupfer C, Thomas PG, Anand PK, et al. Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection. Nat Immunol 2013, 14:480-488.
197. Eklind S, Mallard C, Leverin AL, et al. Bacterial endotoxin sensitizes the immature brain to hypoxic--ischaemic injury. Eur J Neurosci 2001, 13:1101-1106.
198. Lehnardt S, Lachance C, Patrizi S, et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 2002, 22:2478-2486.
199. Du X, Fleiss B, Li H, et al. Systemic stimulation of TLR2 impairs neonatal mouse brain development. PLoS One 2011, 6:e19583.
200. Stridh L, Smith PL, Naylor AS, Wang X, Mallard C Regulation of toll-like receptor 1 and -2 in neonatal mice brains after hypoxia-ischemia. J Neuroinflammation 2011, 8:45.
201. Wang X, Stridh L, Li W, et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 2009, 183:7471-7477.
202. Kendall GS, Hristova M, Horn S, et al. TNF gene cluster deletion abolishes lipopolysaccharide-mediated sensitization of the neonatal brain to hypoxic ischemic insult. Lab Invest 2011, 91:328-341.
203. Mallard C, Wang X, Hagberg H The role of Toll-like receptors in perinatal brain injury. Clin Perinatol 2009, 36:763-772. v-vi.
204. Liu XH, Kwon D, Schielke GP, Yang GY, Silverstein FS, Barks JD Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab 1999, 19:1099-1108.
205. Hedtjärn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002, 22:5910-5919.